focus -WSS

focus

author：fashion 2025-09-29 22:47:26 - browse：33

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Eli Lilly reports tirzepatide MASH success during Q4 earnings

WSS

U.K. Biobank has 500,000 peoples' genome sequences available

BIO selects John Crowley as new CEO

What don’t we know about an Alzheimer’s drug side effect?

U.K. Biobank has 500,000 peoples' genome sequences available

Mayo Clinic plans $5B tech

Diagnostic tests are hitting their mathematical limits

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Virginia high school admissions case could be legal follow

Fetal surgery at risk from Dobbs and new abortion restrictions

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Wildfire smoke exposes gaps in outdoor worker protections

BIO selects John Crowley as new CEO

New air purifier tech could be key to improving indoor air quality

How to pay for weight loss drugs and save Medicare

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

BIO selects John Crowley as new CEO

knowledge

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

How to pay for weight loss drugs and save Medicare

Why Eli Lilly’s earnings didn’t quite live up to the hype

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Having children helps parents live longer, especially after age 80

Wikipedia

focus

leisure time

entertainment